南美洲和中美洲心律失常监测设备市场预测至 2028 年 - COVID-19 影响和区域分析(按类型(心电图监护仪、植入式监护仪、动态心电图监护仪、移动心脏遥测等)、应用(心动过缓、心动过速、心房颤动、心室颤动) 、早宫缩等)和最终用户(医院和诊所、门诊中心、诊断中心等)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 88    |    Report Code: TIPRE00023738    |    Category: Life Sciences

South and Central America Arrythmia Monitoring Devices Market

市场介绍

南美洲和中美洲(SCAM)地区包括巴西、阿根廷以及南美洲和中美洲的其他地区。由于发达和成熟的医疗保健行业的存在、政府的不断增加的支持以及不断增加的研究和开发,这些国家可能会提供增长机会。巴西是世界上面积和人口第五大国,并且正在经历全球最快的人口老龄化。在巴西,在区域和历史社会经济不平等的背景下,人口老龄化速度很快。根据在巴西进行的研究,妇女群体估计占绝大多数,老年人口数量为 1,690 万(56%),而老年人估计约有 1,690 万(56%)。 1330 万(44%)。人口老龄化的加剧导致心血管疾病的发病率增加。这种不断增长的情况可能会推动医疗设备的采用,最终将在预测期内推动巴西心律失常监测设备市场的发展。根据世界卫生组织 (WHO) 的数据,2016 年总死亡人数中约有 28% 是由心血管疾病造成的。导致心血管疾病增加的因素是吸烟、肥胖和高血压患病率的增加。根据世界卫生组织(WHO)的数据,2016年,巴西22%的人口肥胖,14%的人口吸烟,23%的人口患有高血压。这进一步可能会在未来几年促进巴西市场的增长

 

南美洲和中美洲的心律失常监测设备市场包括巴西、阿根廷、和其他南美国家。截至 2021 年 6 月 23 日,南美洲已报告了 3180 万例病例。据报告,COVID-19 病例数不断增加,例如巴西(18,056,639)、阿根廷(4,298,782)、哥伦比亚(3,997,021)和智利(1,525,663) 。南美洲相当多的国家医疗基础设施非常不发达。此外,该地区心律失常监测的可用性也明显较低。例如,秘鲁的 3200 万居民只有不到 1000 个重症监护病房床位。此外,由于港口拥堵和其他运输方式的干扰造成的供应链中断对该地区心律失常监测和其他相关设备的分布产生了重大影响。所有这些因素都极大地阻碍了南美洲和中美洲心律失常监测设备市场的增长。

市场概况和动态

SCAM 心律失常监测设备市场预计将从 2021 年的 3.4222 亿美元增长到 2028 年的 5.0534 亿美元;预计 2021 年至 2028 年复合年增长率为 5.7%。市场整合、技术相关趋势的变化或转变鼓励参与者开发创新设备。符合 HIPPA 标准的技术的最新发展使得整个监控期间的数据传输安全无延迟。新兴技术为传统动态心电图监测仪提供了有效的替代方案,传统动态心电图监测仪为心律失常高风险患者发出警报。因此,这些设备的连续远程监控功能促进了长期、不间断的心律管理,这增加了它们的受欢迎程度。移动心脏遥测(MCT)系统是一种帮助监测心脏病患者心脏状况的创新产品。患者全天携带微型传感器和监视器,每当发生心脏事件时,MCT 都会将数据发送到中央系统进行分析和反应。该系统会生成一份报告,并与患者的医生共享该报告以及图表和趋势,以采取进一步的行动。 MCT 系统能够分析每次心跳,对患者的正常生活几乎没有干扰,并根据需要立即启动紧急响应,这使其成为心脏监测中最有吸引力的选择之一。这促进了心律失常监测设备市场的增长。

关键细分市场

从类型来看,动态心电监护仪细分市场在2020年SCAM心律失常监测设备市场中占据最大份额。从应用来看,心房颤动细分市场在2020年心律失常监测设备市场中占有较大的市场份额。 2020 年,基于最终用户,医院和诊所细分市场占据了更大的市场份额。

主要来源和上市公司

准备本 SCAM 心律失常监测设备市场报告时参考的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有雅培(Abbott);百多力公司;通用电气公司; Hill-Rom 控股公司;皇家飞利浦公司;美敦力

;

其中

 

原因购买报告

  • 了解 SCAM 心律失常监测设备市场格局,并确定最有可能保证强劲的细分市场返回
  • 了解 SCAM 心律失常监测设备市场不断变化的竞争格局,保持领先地位
  • 通过识别,有效规划 SCAM 心律失常监测设备市场的并购和合作交易具有最有前景的可能销售的细分市场
  • 通过对 SCAM 心律失常监测设备市场各个细分市场的市场表现进行敏锐和全面的分析,帮助做出明智的业务决策
  • 获得以下市场的市场收入预测: 2021-2028 年 SCAM 地区各个细分市场的市场

SCAMARRYTHMIA 监控设备市场细分

SCAM 心律失常监测设备市场 –按类型

  • 心电图监护仪
  • 植入式监护仪
  • 动态心电监护仪
  • 移动心脏遥测
  • 其他

SCAM 心律失常监测设备市场 –按

应用

  • 心动过缓
  • 心动过速
  • 心房颤动
  • 心室颤动
  • 早搏
  • 其他

SCAM心律失常监测设备市场 -由

最终用户

  • 医院和诊所
  • 门诊中心
  • 诊断中心
  • 其他

SCAM心律失常监测设备市场,按国家/地区

  • 巴西
  • 阿根廷
  • SCAM 的其余部分

SCAM 心律失常监测设备市场 -提及的公司

  • 雅培
  • Biotronik, Inc.
  • 通用电气公司
  • Hill- Rom Holding Inc.
  • Koninklijke Philips NV
  • 美敦力
 

South and Central America Arrythmia Monitoring Devices Strategic Insights

Strategic insights for South and Central America Arrythmia Monitoring Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-arrythmia-monitoring-devices-market-strategic-framework.webp
Get more information on this report

South and Central America Arrythmia Monitoring Devices Report Scope

Report Attribute Details
Market size in 2021 US$ 342.22 Million
Market Size by 2028 US$ 505.34 Million
Global CAGR (2021 - 2028) 5.7%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 类型
  • 心电图监测仪
  • 植入式监测仪
  • 动态心电图监测仪
  • 移动心脏遥测
By 应用
  • 心动过缓
  • 心动过速
  • 心房颤动
  • 心室颤动
  • 期前收缩
By 最终用户
  • 医院和诊所
  • 门诊中心
  • 诊断中心
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Abbott
  • Biotronik, Inc.
  • General Electric Company
  • Hill-Rom Holding Inc.
  • Koninklijke Philips N.V.
  • Medtronic
  • Get more information on this report

    South and Central America Arrythmia Monitoring Devices Regional Insights

    The regional scope of South and Central America Arrythmia Monitoring Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-arrythmia-monitoring-devices-market-geography.webp
    Get more information on this report

    The List of Companies - South and Central America Arrythmia Monitoring Devices Market

    1. Abbott
    2. Biotronik, Inc.
    3. General Electric Company
    4. Hill-Rom Holding Inc. 
    5. Koninklijke Philips N.V.
    6. Medtronic
    Frequently Asked Questions
    How big is the South and Central America Arrythmia Monitoring Devices Market?

    The South and Central America Arrythmia Monitoring Devices Market is valued at US$ 342.22 Million in 2021, it is projected to reach US$ 505.34 Million by 2028.

    What is the CAGR for South and Central America Arrythmia Monitoring Devices Market by (2021 - 2028)?

    As per our report South and Central America Arrythmia Monitoring Devices Market, the market size is valued at US$ 342.22 Million in 2021, projecting it to reach US$ 505.34 Million by 2028. This translates to a CAGR of approximately 5.7% during the forecast period.

    What segments are covered in this report?

    The South and Central America Arrythmia Monitoring Devices Market report typically cover these key segments-

  • 类型 (心电图监测仪, 植入式监测仪, 动态心电图监测仪, 移动心脏遥测)
  • 应用 (心动过缓, 心动过速, 心房颤动, 心室颤动, 期前收缩)
  • 最终用户 (医院和诊所, 门诊中心, 诊断中心)
  • What is the historic period, base year, and forecast period taken for South and Central America Arrythmia Monitoring Devices Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Arrythmia Monitoring Devices Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in South and Central America Arrythmia Monitoring Devices Market?

    The South and Central America Arrythmia Monitoring Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott
  • Biotronik, Inc.
  • General Electric Company
  • Hill-Rom Holding Inc.
  • Koninklijke Philips N.V.
  • Medtronic
  • Who should buy this report?

    The South and Central America Arrythmia Monitoring Devices Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South and Central America Arrythmia Monitoring Devices Market value chain can benefit from the information contained in a comprehensive market report.